Company Quick10K Filing
Athena Silver
10-Q 2020-03-31 Filed 2020-05-18
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-30
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-04-05
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-03
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-10-18
10-Q 2013-06-30 Filed 2013-08-15
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-15
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-16
10-Q 2012-03-31 Filed 2012-05-21
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-17
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-18
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-21
10-K 2009-12-31 Filed 2010-05-04
8-K 2020-04-28
8-K 2020-02-21
8-K 2019-11-05
8-K 2018-07-31
8-K 2018-06-27
8-K 2018-05-15

Athena Silver Financials

AHNR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
NioCorp Developments (NIOBF) 0.0 -62% 10,720 6,057 0 0 -6,610 -6,383 -46
Nestor Partners (C471) 0% 155,359 2,907 0 0 0 0 -12,534
Credex (CRDX) 0.0 0 72 0 0 -7 -7 -0
Skinovation Pharmaceutical (SKIN) 0.0 -24,889% 0 307 0 0 -23 -11 -0
Bergio International (BRGO) 65% 0.0 -18% 1,434 2,329 695 450 -258 -338 -0
Cleantech Biofuels (CLTH) 0.0 -13% 2,188 7,443 0 0 -290 -22 -0
Mikrocoze (MRCZ) 0.0 -35,402% 0 47 0 0 -18 -18 -0
Altegris Qim Futures Fund (AQIM) 0.5 -15% 13,755 1,750 0 0 -2,052 -2,047 -1,008
8i Enterprises Acquisition Corp (JFKKU)
General Motors Financial (ACF) 0% 17.9 1% 109,361,000 96,673,000 14,517,000 0 1,508,000 4,702,000 84,241,000
Global House Holdings (KLDK) 0.0 -179% 20 84 0 0 -36 -36 -0
Athena Silver (AHNR) -0.7 -115% 189 3,024 0 0 -217 -134 90
Adveco Group (ADVV) 14% 0.0 -38% 9,267 21,482 1,743 247 -3,565 -3,562 -0
Markham Woods (MWPP) 0.2 16,188,400% 0 0 -162 -46 -9
Potomac Futures Fund (POTO) -1.7 15% 39,002 765 0 0 5,745 5,745 -9,851
AEI Income & Growth Fund 26 (AEI26) 1.4 -8% 9,648 362 0 0 -791 -496 -671
Creative Medical Technology (CELZ) 76% -0.8 -996% 330 3,893 170 128 -3,292 -1,804 1,374
Digital Development Partners (DGDM) 0.0 -5,818% 2 1,110 0 0 -89 -58 -2
Williams Partners (WPZ) 0% 5.1 2% 45,938,000 24,399,000 8,277,000 0 775,000 3,293,000 16,763,000
Sunvalley Solar (SUNV) 16% 0.6 -181,286,500% 3,031 494 1,813 1,819 1,020

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash23529176124321743384411221211310714500
Accounts Receivable
Inventory
PP&E
Assets4804865408381,1791,6251,6441,6621,7061,7161,7611,7921,7671,7991,9571,9791,9862,0412,0402,0722,0702,1222,1222,119228256260252189200192189
Accounts Payable7939111108129928882707761596910355612845322516262218422213228494634
Long-Term Debt1301301301201201201201101101101101001001001009090
Liabilities1822754116178099831,0641,1231,2001,2951,3731,4351,4541,5581,8291,8911,9512,1362,2062,2682,3172,4392,5182,5102,5902,6782,7372,7872,8232,9282,9723,024
Stockholders' Equity2982121292213716425795395074223883573132411288836-95-166-196-246-317-396-392-2,362-2,422-2,477-2,535-2,633-2,729-2,781-2,835
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A884472655340200382049-132825512828265329232848253727454339442526
Tax000000000000
Net Income-234-98-138-111-180-68-217-40-32-85-791-43-95-112-40-52-131-71-30-50-71-784-1,970-60-72-58-110-52-54
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-97-55-183-78-56-46-45-43-41-34-29-49-55-48-58-33-29-36-26-42-23-28-31-49-25-24-56-31-28
Cash Investing-22-71-127-205000-90-21-6-0-30-10-9-2-43-3-750-45000-2100000
Cash Financing1011501462745545601206140357565546077321102686232929703118582628